Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Worta McCaskill-Stevens

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Annals of Surgical Oncology|January 6, 2010
p53 as a marker of prognosis in African-American women with breast cancerKeith A Dookeran, James J Dignam, Karen Ferrer, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
A critical review of the enrollment of black patients in cancer clinical trialsDeliya R Banda, Diane St Germain, Worta McCaskill-Stevens, et al.
Cancer|September 18, 2007
Challenges and recommendations for advancing the state-of-the-science of quality of life assessment in symptom management trialsDavid R Buchanan, Ann M O'Mara, Joseph W Kelaghan, et al.
Annals of Surgical Oncology|March 22, 2012
Race and the prognostic influence of p53 in women with breast cancerKeith A Dookeran, James J Dignam, Nathaniel Holloway, et al.
CA: a Cancer Journal for Clinicians|April 15, 2003
Prevention and early detection clinical trials: opportunities for primary care providers and their patientsLeslie G Ford, Lori M Minasian, Worta McCaskill-Stevens, et al.
Journal of the American College of Cardiology|June 8, 2019
Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast CancerMaya Guglin, Jeffrey Krischer, Roy Tamura, et al.
Journal of the National Cancer Institute|April 3, 2003
Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemopreventionAndrew N Freedman, Barry I Graubard, Sowmya R Rao, et al.
Journal of the National Cancer Institute|December 2, 2004
Contralateral breast cancer and thromboembolic events in African American women treated with tamoxifenWorta McCaskill-Stevens, John Wilson, John Bryant, et al.
JNCI Cancer Spectrum|April 16, 2021
DeImplementing Ineffective and Low-Value Clinical Practices: Research and Practice Opportunities in Community Oncology SettingsWynne E Norton, Worta McCaskill-Stevens, David A Chambers, et al.
Cancer|April 3, 2020
Reporting of health-related quality of life endpoints in National Cancer Institute-supported cancer treatment trialsDiane St Germain, Andrea Denicoff, Andrea Torres, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Annals of Surgical Oncology|January 6, 2010
p53 as a marker of prognosis in African-American women with breast cancerKeith A Dookeran, James J Dignam, Karen Ferrer, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
A critical review of the enrollment of black patients in cancer clinical trialsDeliya R Banda, Diane St Germain, Worta McCaskill-Stevens, et al.
Cancer|September 18, 2007
Challenges and recommendations for advancing the state-of-the-science of quality of life assessment in symptom management trialsDavid R Buchanan, Ann M O'Mara, Joseph W Kelaghan, et al.
Annals of Surgical Oncology|March 22, 2012
Race and the prognostic influence of p53 in women with breast cancerKeith A Dookeran, James J Dignam, Nathaniel Holloway, et al.
CA: a Cancer Journal for Clinicians|April 15, 2003
Prevention and early detection clinical trials: opportunities for primary care providers and their patientsLeslie G Ford, Lori M Minasian, Worta McCaskill-Stevens, et al.
Journal of the American College of Cardiology|June 8, 2019
Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast CancerMaya Guglin, Jeffrey Krischer, Roy Tamura, et al.
Journal of the National Cancer Institute|April 3, 2003
Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemopreventionAndrew N Freedman, Barry I Graubard, Sowmya R Rao, et al.
Journal of the National Cancer Institute|December 2, 2004
Contralateral breast cancer and thromboembolic events in African American women treated with tamoxifenWorta McCaskill-Stevens, John Wilson, John Bryant, et al.
JNCI Cancer Spectrum|April 16, 2021
DeImplementing Ineffective and Low-Value Clinical Practices: Research and Practice Opportunities in Community Oncology SettingsWynne E Norton, Worta McCaskill-Stevens, David A Chambers, et al.
Cancer|April 3, 2020
Reporting of health-related quality of life endpoints in National Cancer Institute-supported cancer treatment trialsDiane St Germain, Andrea Denicoff, Andrea Torres, et al.
Pageof 7